Concepedia

Seerapani Gopaluni

SG

16

Publications

819

Citations

13

H-Index

2009

Active since

Affiliations

University of Cambridge(Current)

Addenbrooke's Hospital

University College London

Imperial College London

The Royal Free Hospital

Seerapani Gopaluni is an author at University of Cambridge specializing in medicine, rheumatology, and epidemiology.

ORCID

Top concepts

Publications per year

2009–2023

16

Publications

16

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

Stephen P. McAdoo, Nicholas Medjeral‐Thomas, Seerapani Gopaluni et al. · Nephrology Dialysis Transplantation · 2017 · 154 citations · Full text

Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis

Andreas Kronbichler, Julia Kerschbaum, Seerapani Gopaluni et al. · Annals of the Rheumatic Diseases · 2018 · 143 citations · Full text

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease

Joanna Tieu, Rona Smith, Seerapani Gopaluni et al. · Frontiers in Immunology · 2021 · 96 citations · Full text

A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis

Ruth J. Pepper, Stephen P. McAdoo, Sarah Moran et al. · Lara D. Veeken · 2018 · 95 citations · Full text

Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis

Mark McClure, James Wason, Seerapani Gopaluni et al. · JCR Journal of Clinical Rheumatology · 2019 · 62 citations · Full text

Rows per page

1–5 of 16